Fidelity Investments’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $823M | Buy |
5,488,272
+1,372,191
| +33% | +$149M | 0.04% | 384 |
|
|
2026
Q1 | $380M | Buy |
4,116,081
+1,719,648
| +72% | +$173M | 0.02% | 612 |
|
|
2025
Q4 | $245M | Buy |
2,396,433
+1,572,168
| +191% | +$141M | 0.01% | 780 |
|
|
2025
Q3 | $51.5M | Sell |
824,265
-163,410
| -17% | -$8.89M | ﹤0.01% | 1427 |
|
|
2025
Q2 | $51.4M | Buy |
987,675
+497,746
| +102% | +$22.2M | ﹤0.01% | 1385 |
|
|
2025
Q1 | $20.9M | Sell |
489,929
-669,682
| -58% | -$28.9M | ﹤0.01% | 1664 |
|
|
2024
Q4 | $35.4M | Sell |
1,159,611
-312,191
| -21% | -$8.78M | ﹤0.01% | 1515 |
|
|
2024
Q3 | $33.8M | Sell |
1,471,802
-1,646,821
| -53% | -$46.6M | ﹤0.01% | 1530 |
|
|
2024
Q2 | $90.1M | Buy |
3,118,623
+92,113
| +3% | +$2.14M | 0.01% | 1092 |
|
|
2024
Q1 | $62.4M | Sell |
3,026,510
-2,224,839
| -42% | -$47.7M | ﹤0.01% | 1241 |
|
|
2023
Q4 | $142M | Sell |
5,251,349
-3,276,949
| -38% | -$86M | 0.01% | 883 |
|
|
2023
Q3 | $253M | Sell |
8,528,298
-274,248
| -3% | -$9.64M | 0.02% | 612 |
|
|
2023
Q2 | $315M | Buy |
8,802,546
+36,555
| +0.4% | +$1.05M | 0.03% | 560 |
|
|
2023
Q1 | $205M | Sell |
8,765,991
-6,540,503
| -43% | -$187M | 0.02% | 696 |
|
|
2022
Q4 | $416M | Buy |
15,306,494
+72,560
| +0.5% | +$3.32M | 0.04% | 458 |
|
|
2022
Q3 | $820M | Buy |
15,233,934
+476,699
| +3% | +$24.5M | 0.09% | 217 |
|
|
2022
Q2 | $595M | Buy |
14,757,235
+5,242,407
| +55% | +$260M | 0.06% | 316 |
|
|
2022
Q1 | $630M | Buy |
9,514,828
+2,054,281
| +28% | +$141M | 0.05% | 367 |
|
|
2021
Q4 | $746M | Buy |
7,460,547
+1,046,235
| +16% | +$108M | 0.06% | 325 |
|
|
2021
Q3 | $802M | Buy |
6,414,312
+775,142
| +14% | +$92.1M | 0.06% | 286 |
|
|
2021
Q2 | $700M | Sell |
5,639,170
-1,061,463
| -16% | -$143M | 0.05% | 339 |
|
|
2021
Q1 | $1.02B | Buy |
6,700,633
+3,931,002
| +142% | +$594M | 0.09% | 216 |
|
|
2020
Q4 | $357M | Buy |
2,769,631
+1,764,865
| +176% | +$203M | 0.03% | 508 |
|
|
2020
Q3 | $112M | Buy |
1,004,766
+205,546
| +26% | +$18.8M | 0.01% | 860 |
|
|
2020
Q2 | $64.8M | Buy |
799,220
+51,237
| +7% | +$4.13M | 0.01% | 1065 |
|
|
2020
Q1 | $52.1M | Buy |
747,983
+118,252
| +19% | +$9.07M | 0.01% | 1017 |
|
|
2019
Q4 | $49.2M | Buy |
629,731
+8,391
| +1% | +$605K | 0.01% | 1217 |
|
|
2019
Q3 | $39.7M | Buy |
621,340
+30,525
| +5% | +$2.69M | ﹤0.01% | 1283 |
|
|
2019
Q2 | $51M | Buy |
590,815
+126,203
| +27% | +$9.64M | 0.01% | 1207 |
|
|
2019
Q1 | $35.6M | Buy |
464,612
+102,483
| +28% | +$5.68M | ﹤0.01% | 1361 |
|
|
2018
Q4 | $13.6M | Buy |
+362,129
| New | +$13.3M | ﹤0.01% | 1698 |
|
Other funds holding GH
DTC
Fidelity Investments's GH Position: Q2 2026 in Review
Fidelity Investments increased its Guardant Health (GH) stake by 33% in Q2 2026, buying an estimated $149M and bringing the position to 5,488,272 shares worth $823M. The position accounts for 0.04% of the portfolio, ranked #384.
Fidelity Investments first reported a position in GH in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.02B in Q1 2021. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Fidelity Investments held 5,488,272 shares of Guardant Health worth $823M as of Q2 2026.
- Fidelity Investments bought 1,372,191 Guardant Health shares in Q2 2026, an estimated $149M.
- Guardant Health made up 0.04% of Fidelity Investments's portfolio in Q2 2026, its #384 holding.
- Fidelity Investments first reported a position in Guardant Health in Q4 2018 and has held it in 31 quarters since.
- Fidelity Investments's Guardant Health position peaked at $1.02B in Q1 2021.
- 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.